KRISTIN GALLINOT: Open Payments
NPI 1245864297 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,834 in 55 payments from 14 companies in 2025. Trend: 2023 $1,186 · 2024 $1,205 · 2025 $1,834
Food & beverage: $1,834
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 32 | $1,049 |
| Janssen Biotech, Inc. | 9 | $231 |
| Janssen Scientific Affairs, LLC | 1 | $146 |
| Astellas Pharma Global Development | 1 | $132 |
| Teleflex LLC | 1 | $40 |
| Boston Scientific Corporation | 2 | $39 |
| TOLMAR, INC. | 1 | $35 |
| Procept Biorobotics Corporation | 1 | $26 |
| UROGEN PHARMA, INC. | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
Products named: GEMTESA, ERLEADA, Xtandi, BARRIGEL, AQUABEAM ROBOTIC SYSTEM, PROLARIS, Bovie, Axonics.
Industry payments across CA — which companies pay providers there.
